l19sip
mAbexperimentalADC
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- FibronectinINHIBITOR
FN1 inhibitor
- FibronectinOTHER
FN1 other
Used as radiolabelled antibody radretumab.
Targets the ED-B domain of Fibronectin.
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
- Payload
- 131-iodine
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109412 ↗
Also known as
- l19sip
- l19sip 131i